David F Williams Selected Research

David F Williams Research Topics

5	Macular Degeneration (Age-Related Maculopathy) 01/2022 - 10/2012
4	Macular Edema 01/2022 - 05/2006
2	Retinal Vein Occlusion 01/2022 - 12/2021
2	Retinal Perforations 08/2019 - 11/2011
2	Retinal Detachment (Retinal Detachments) 08/2019 - 11/2011
2	Inflammation (Inflammations) 01/2017 - 12/2014
2	Osteoarthritis 12/2014 - 07/2013
2	Neoplasms (Cancer) 05/2014 - 04/2013
1	Heart Valve Diseases (Valvular Heart Disease) 01/2022
1	Rheumatic Heart Disease (Rheumatic Heart Diseases) 01/2021
1	Myopia 08/2019
1	Hypotension (Low Blood Pressure) 01/2019
1	Endophthalmitis (Ophthalmia) 01/2018
1	Fibrosis (Cirrhosis) 01/2017
1	Geographic Atrophy 01/2017
1	Heart Failure 01/2015
1	Thrombosis (Thrombus) 01/2015
1	Pelvic Organ Prolapse 05/2014
1	Rheumatic Diseases (Rheumatism) 07/2013
1	Body Weight (Weight, Body) 04/2013
1	Breast Neoplasms (Breast Cancer) 04/2013
1	Cardiotoxicity 04/2013
1	Diabetic Retinopathy (Retinopathy, Diabetic) 03/2013
1	Stroke (Strokes) 10/2012
1	Choroidal Neovascularization 10/2012
1	Osteoporosis 09/2012
1	Disease Progression 03/2007
1	Hemorrhage 03/2007
1	Edema (Dropsy) 05/2006
1	Weight Gain 05/2006
1	Weight Loss (Weight Reduction) 05/2006
1	Infections 07/2004

6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 01/2018
2	Biocompatible Materials (Biomaterials)IBA 01/2017 - 05/2014
2	Pharmaceutical PreparationsIBA 04/2013 - 05/2006
2	Retinaldehyde (Retinal)IBA 03/2013 - 11/2011
1	PolymersIBA 01/2022
1	Endothelial Growth FactorsIBA 12/2021
1	InflammasomesIBA 01/2017
1	lampalizumabIBA 01/2017
1	salicylhydroxamic acid (SHAM)IBA 01/2017
1	chemotactic factor inactivatorIBA 01/2017
1	Complement Factor D (Factor D)IBA 01/2017
1	Complement Factor I (C3b Inactivator)IBA 01/2017
1	Siloxanes (Siloxane)IBA 01/2015
1	Polyurethanes (Polyurethane)IBA 01/2015
1	polycarbonateIBA 01/2015
1	Biological ProductsIBA 12/2014
1	Hyaluronic Acid (Hyaluronan)IBA 12/2014
1	Polypropylenes (Polypropylene)IBA 05/2014
1	CytokinesIBA 07/2013
1	MicellesIBA 04/2013
1	Inosine Diphosphate (IDP)IBA 03/2013
1	Ranibizumab (Lucentis)FDA Link 10/2012
1	Therapeutic UsesIBA 09/2012
1	Warfarin (Coumadin)FDA LinkGeneric 03/2007
1	Rosiglitazone (Avandia)FDA Link 05/2006
1	ThiazolidinedionesIBA 05/2006
1	Pioglitazone (Actos)FDA Link 05/2006
1	Biological Control AgentsIBA 07/2004